Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers

NCT05333276 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: TQB3602 Capsule + AK105 Injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.